Global Monoclonal Antibodies in Veterinary Health Market Size Projected to be Worth USD 3,425.91 Million By 2032, at 15.98% CAGR: Polaris Market Research

Polaris Market Research conducted a comprehensive research study spanning over [+115] pages, revealing that the global monoclonal antibodies in veterinary health market size/share is expected to reach USD 785.71 Million in 2022. The study further indicates that the market will grow at a compound annual growth rate (CAGR) of 15.98% and is projected to touch USD 3,425.91 Million By 2032. The dogs segment accounted for the highest revenue share in 2022 due to the growing number of pet dogs and their expensive healthcare, driven by the rising prevalence of chronic diseases and pet insurance adoption. Some of the major players are Adivo GmbH, Bayer Animal Health, Boehringer Ingelheim GmbH, Elanco and others.

New York, NY, June 08, 2023 (GLOBE NEWSWIRE) -- Polaris Market Research has published a new research report titled "Monoclonal Antibodies in Veterinary Health Market Share, Size, Trends, Industry Analysis Report, By Animal Type (Dogs, Others); By Application (Dermatology, Pain, Others); By End-Use; By Region; Segment Forecast, 2023 - 2032" in its research database.

"As per the latest research analysis, the global monoclonal antibodies in veterinary health market size/share will be valued at roughly USD 785.71 Million in 2022, and its revenue is projected to reach about USD 3,425.91 Million By 2032. The market is forecasted to expand at a compound annual growth rate of approximately 15.98% between 2023 and 2032."

What is the Market for Monoclonal Antibodies in Veterinary Health?

Overview

Monoclonal antibodies are also commonly known as moAbs or mAbs. It is a kind of laboratory-produced protein that can bind to particular bodily targets, like antigens on the texture of cancer cells. Every monoclonal antibody is developed to attach to a single antigen, and numerous varieties of these antibodies exist.

Many diseases, including some forms of cancer, are diagnosed and treated using monoclonal antibodies. The monoclonal antibodies in veterinary health market are expanding due to the creation of novel monoclonal antibodies, rising pet costs, allergy therapies, and an increase in cancer cases, particularly in dogs.

Request Sample Copy of Monoclonal Antibodies in Veterinary Health Market Research Report @ https://www.polarismarketresearch.com/industry-analysis/monoclonal-antibodies-in-veterinary-health-market/request-for-sample

(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)

Our Sample Report Covers:

2032 Updated Report Introduction, Overview, and In-depth industry analysis.

115+ Pages Research Report (Inclusion of Updated Research).

Provide Chapter-wise guidance on Requests.

2023 Updated Regional Analysis with Graphical Representation of Size, Share & Trends

Includes Updated List of tables & figures.

Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis.

Some of the Top Market Players Are:

Adivo GmbH

Bayer Animal Health

Boehringer Ingelheim GmbH

Elanco; Indian Immunologicals Ltd.

Invetx

Kindred Biosciences Inc.

Merck & Co. Inc

Nextmune

Virbac

Zoetis

To Know an Additional List of Key Players, Request Here to Download a Free Report PDF Brochure: https://www.polarismarketresearch.com/industry-analysis/monoclonal-antibodies-in-veterinary-health-market/request-for-sample

Prominent Growth Driving Factors

Expanded prevalence of chronic diseases: One of the primary drivers of the increasing monoclonal antibodies in veterinary health market share is the rising prevalence of chronic diseases in companion animals, such as cancer and arthritis. The mAbs treat infectious disorders like parvovirus, feline leukemia virus, and chronic diseases. mAbs are a crucial tool in veterinary medicine because of their ability to increase animal welfare and stop the spread of disease in animal populations.

Technological advancements: The development of more accurate and efficient monoclonal antibodies for veterinary usage is facilitated by biotechnology advances. Innovative medicines are possible through advanced technology like bioprinting and gene editing. These developments should accelerate the market's expansion even more.

Increasing pet ownership: The market is expanding because of growing pet ownership and spending. Pet owners are ready to spend more on their animals' healthcare is driving demand for more advanced and effective treatments like monoclonal antibodies.

Top Findings of the Report

The monoclonal antibodies in veterinary health market size are expanded due to the rising pet adoption rate. Additionally, the industry is making significant investments in cancer treatment research & development, which is anticipated further to fuel market expansion throughout the anticipated period.

The market segmentation is based on application, animal type, region, and end-use.

North America dominates the market during the forecast period.

Request for a Discount on this Report Before Purchase @ https://www.polarismarketresearch.com/industry-analysis/monoclonal-antibodies-in-veterinary-health-market/request-for-discount-pricing

Top Trends Influencing the Market

Treating chronic disorders: The monoclonal antibodies in veterinary health market growth is anticipated to expand rapidly as chronic diseases, including diabetes, cancer, and autoimmune disorders, become increasingly prevalent in animals, just as they are in humans. These disorders can be effectively and precisely treated using monoclonal antibodies, which has raised the demand for these treatments.

Collaborations and partnerships: More innovative treatments for animal disorders are being developed due to partnerships and cooperation between biotech and pharmaceutical businesses, veterinary clinics, and research organizations. Market growth is anticipated to be further accelerated by regulatory approvals of monoclonal antibodies for veterinary medicine by regulatory organizations like the FDA and EMA.

Segmental Analysis

Dogs sector accounts for the highest revenue share

Due to the increasing popularity of dogs as pets and the rising cost of maintaining their health, the dogs segment had the biggest revenue share. The rise in pet insurance adoption and the prevalence of chronic animal diseases have contributed to the market's revenue growth.

Moreover, the market is growing as pet insurance is increasingly popular. More people will spend more on their pets' medical care, including advanced treatments like monoclonal antibodies. This trend is anticipated to accelerate monoclonal antibodies in veterinary health market demand.

The veterinary hospital sector dominates the market

The veterinary hospital sector dominated the market's revenue share. The expansion of veterinary hospitals and veterinarians is responsible for the industry's growth. Due to the accessibility of innovative treatments, veterinary hospitals have made huge profits.

Moreover, the "others" sector of the market, which includes research organizations, veterinary clinics, and academic institutions, is anticipated to see revenue growth.

Inquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/monoclonal-antibodies-in-veterinary-health-market/inquire-before-buying

(Inquire about a report quote OR available discount offers to the sales team before purchase.)

Monoclonal Antibodies in Veterinary Health Market: Report Scope

Report Attribute

Details

Revenue forecast in 2032

USD 3,425.91 Million

Market size value in 2023

USD 902.43 Million

Expected CAGR Growth

15.98% from 2023 – 2032

Base Year

2022

Forecast Year

2023 – 2032

Top Market Players

Adivo GmbH, Bayer Animal Health, Boehringer Ingelheim GmbH, Elanco; Indian Immunologicals Ltd., Invetx, Kindred Biosciences, Inc., Merck & Co. Inc, Nextmune, Virbac, Zoetis

Segments Covered

By Animal Type, By Application, By End-Use, By Region

Customization Options

Customized purchase options are available to meet any research needs. Explore customized purchase options

Geographical Overview

North America: Due to the initiatives supported by the public and private sectors and the rising popularity of pet insurance, the North American region dominated the global market. The presence of prominent market players further increases the market growth.

Asia Pacific: The monoclonal antibodies in veterinary health market in Asia Pacific are anticipated to have the biggest revenue share despite the growing number of veterinary hospitals and clinics in the area that competes with it. The industry is expected to develop as pet adoption rises, disease awareness increases, and more alternative therapy types are available.

Browse the Detail Report "Monoclonal Antibodies in Veterinary Health Market Share, Size, Trends, Industry Analysis Report, By Animal Type (Dogs, Others); By Application (Dermatology, Pain, Others); By End-Use; By Region; Segment Forecast, 2023 - 2032" with in-depth TOC: https://www.polarismarketresearch.com/industry-analysis/monoclonal-antibodies-in-veterinary-health-market

For Additional Information OR Media Enquiry, Please Mail At: [email protected]

Recent Developments

Elanco announced an agreement to purchase Kindred Biosciences in August 2021. The deal completes the pipeline, boosts the R&D capacity for monoclonal antibodies, and includes three potential blockbusters in the development stage.

Invetx, a Boston-based leader in protein-based therapeutics for animal health, and Boehringer Ingelheim, a global leader in veterinary medicine, announced in September 2021 that they had collaborated to develop novel, species-specific monoclonal antibody biotherapeutics that will initially target illnesses in dogs and cats.

The Report Answers Questions Such as

What is the estimated market value of monoclonal antibodies in veterinary health?

What are the key market growth drivers?

Who are the key players in the industry?

What opportunities and trends drive the monoclonal antibodies in the veterinary health market?

Which segment holds the highest market share?

At what CAGR is the market expected to grow during the forecast period?

Polaris Market Research has segmented the Monoclonal Antibodies in Veterinary Health market report based on animal type, application, end-user, and region:

By Animal Type Outlook

Dogs

Others

By Application Outlook

Dermatology

Pain

Others

By End-Use Outlook

Veterinary hospitals

Others

By Region Outlook

North America (U.S., Canada)

Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)

Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)

Latin America (Brazil, Mexico, Argentina)

Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Browse More Research Reports:

Cash Management Systems Market: https://www.polarismarketresearch.com/industry-analysis/cash-management-system-market

Pipe Insulation Market: https://www.polarismarketresearch.com/industry-analysis/pipe-insulation-market

Almond Butter Market: https://www.polarismarketresearch.com/industry-analysis/almond-butter-market

BFSI Crisis Management Market: https://www.polarismarketresearch.com/industry-analysis/bfsi-crisis-management-market

Low-speed electric vehicle (LSEV) Market: https://www.polarismarketresearch.com/industry-analysis/low-speed-electric-vehicle-lsev-market

Thin Film Encapsulation Market: https://www.polarismarketresearch.com/industry-analysis/thin-film-encapsulation-tfe-market

Fishmeal and Fish Oil Market: https://www.polarismarketresearch.com/industry-analysis/fishmeal-and-fish-oil-market

About Polaris Market Research:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

Contact:

Likhil G

30 Wall Street8th Floor,New York City, NY 10005,United StatesPhone: +1-929 297-9727Email: [email protected]: https://www.polarismarketresearch.com Follow Us: LinkedIn | Twitter

Blog: https://polarismarketresearch.medium.com | https://polarisnewsblog.com